GSK press releases Follow Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma SWIFT data included reduction in exacerbations requiring hospitalisation and/or emergency department visits with depemokimab. https://www.gsk.com/en-gb/media/press-releases/exdensur-depemokimab-approved-by-us-fda-for-the-treatment-of-severe-asthma/ gsk.com
